LeafNLP Demos
Back to explore

Report #2880654

Received Jan 5, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
AZ
Recovered
Unknown
Vaccinated
Dec 22, 2025
Onset
Dec 22, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (ENGERIX-B)GLAXOSMITHKLINE BIOLOGICALSUNKjb4k2—

Symptoms (1)

Underdose

Symptom narrative

Pediatric dose administered to adult; Pediatric dose administered to adult; This non-serious case was reported by a other health professional via call center representative and described the occurrence of underdose in a 57-year-old female patient who received HBV (Engerix B pediatric) (batch number jb4k2, expiry date 23-JAN-2027) for prophylaxis. On 22-DEC-2025, the patient received Engerix B pediatric. On 22-DEC-2025, an unknown time after receiving Engerix B pediatric, the patient experienced underdose (Verbatim: Pediatric dose administered to adult) and adult use of a child product (Verbatim: Pediatric dose administered to adult). The outcome of the underdose and adult use of a child product were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.